Previous 10 | Next 10 |
Accolade press release (NASDAQ:ACCD): Q4 GAAP EPS of -$0.51 misses by $0.12. Revenue of $93.76M (+58.4% Y/Y) beats by $2.18M. Shares -30.38%. For further details see: Accolade GAAP EPS of -$0.51 misses by $0.12, revenue of $93.76M beats by $2.18M
Fiscal fourth quarter 2022 revenue of $93.8 million, a 58% increase compared to fiscal fourth quarter 2021 revenue of $59.2 million Fiscal year 2022 revenue of $310.0 million, an 82% increase compared to fiscal year 2021 revenue of $170.4 million SEATTLE, April 28, 2022 (GLOBE N...
SEATTLE, April 14, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 600 employers and millions of members, today announced that it will release fiscal fourth quarter and full year 2022 financial results on Thursday, April 28, 2022, after th...
Accolade (NASDAQ:ACCD) stock dropped to a 1-month low after Wells Fargo began coverage with an Underweight rating and price target of $9, implying 41.6% downside to its last close. In a note to clients, analyst Stan Berenshteyn said growth prospects for ACCD are attractive and it...
Guggenheim has initiated coverage of employee health benefits support provider Accolade with a neutral rating as the company will not be profitable until fiscal year 2025. The firm does not have a price target. Analyst Sandy Draper said that the company's offerings of personalized, data-drive...
Today, we put healthcare cloud concern Accolade in the spotlight for the first time. Despite solid growth and the addition of new capabilities since the company went public in July 2020, the stock finds itself in 'Busted IPO' territory. Brighter prospects for shareholders on the h...
Accolade Brings Proven Value to the Employee Experience Through Personalized Healthcare PR Newswire New third-party research demonstrates how Accolade enhances employee retention and recruitment, overall experience and satisfaction, and perception of health insuran...
SEATTLE, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 600 employers and millions of members, will participate in the 2022 SVB Leerink Global Healthcare Conference, including a fireside chat presentation on Friday, February 18, 2022 ...
SEATTLE, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 600 employers and millions of members, will participate in 24th Annual Needham Growth Conference, including a presentation on Friday, January 14, 2022 at 12:30 p.m. E.T. A webcas...
Shares of Accolade Inc ( NASDAQ: ACCD ) opened about 25% up on Tuesday after the software and technology company reported better-than-expected financial results for its third quarter last night. Q3 results Accolade said its net income printed at $22.5 million in Q3 that tran...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...